4.6 Article

ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12months

Related references

Note: Only part of the references are listed.
Article Parasitology

Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis

Cristina Ballesteros et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)

Article Microbiology

In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei

Kate E. Mounsey et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Parasitology

Factors influencing US canine heartworm (Dirofilaria immitis) prevalence

Dongmei Wang et al.

PARASITES & VECTORS (2014)

Review Parasitology

Moxidectin and the avermectins: Consanguinity but not identity

Roger Prichard et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)

Article Veterinary Sciences

Heartworm Biology, Treatment, and Control

Dwight D. Bowman et al.

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2009)

Article Pharmacology & Pharmacy

Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs

Sayer I. Al-Azzam et al.

BIOPHARMACEUTICS & DRUG DISPOSITION (2007)

Article Parasitology

Evaluation of efficacy of heartworm preventive products at the FDA

VA Hampshire

VETERINARY PARASITOLOGY (2005)